CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
Generic Name: Miglustat
Brand Name: Zavesca
Manufacturer: Actelion Pharmaceuticals Canada Inc.
Indications: Gaucher disease
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: November 24, 2004
Recommendation Type: Do not list
